General information about company

Name of The CompanyThyrocare Technologies Limited
BSE Scrip Code539871
NSE SymbolTHYROCARE
MSE SymbolNA
Date of Start of Financial Year01-04-2024
Date of End of Financial Year31-03-2025
Reporting PeriodFirst half yearly
Date of Start of Reporting Period01-04-2024
Date of End of Reporting Period30-09-2024
Level of rounding to be used in disclosing related party transactionsCrores
Whether the company has any related party?Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?Yes



(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicNA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?Yes
Latest Date on which RPT policy is updated29-04-2022
Indicate Company website link for updated RPT policy of the Companyhttps://investor.thyrocare.com/corporate-governance-policies/






Related party transactions

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investmentsNotes
NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment )Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1Thyrocare Technologies LimitedAABCT2577PAPI HOLDINGS LIMITEDAASCA1201EUltimate Holding CompanyAny other transactionReimbursement of expenses paid50 As approved by the audit committee0.030.02-0.01Textual Information(1)
2Thyrocare Technologies LimitedAABCT2577PAkna Medical Private LimitedAAQCA8781MFellow subsidiaryAny other transactionRent received10 As approved by the audit committee0.0100.01Textual Information(2)
3Thyrocare Technologies LimitedAABCT2577PAycon Graph Connect Pvt LtdAASCA4283CFellow subsidiaryAny other transactionReimbursement of expenses received50 As approved by the audit committee0.090.210.14Textual Information(3)
4Thyrocare Technologies LimitedAABCT2577PDocon Technologies Private LimitedAAFCD7637LHolding CompanySale of goods or services100 As approved by the audit committee31.0417.311.02Textual Information(4)
5Thyrocare Technologies LimitedAABCT2577PEquinox Labs Private LimitedAAECE7062PAssociate CompanyInvestmentApproved by the Audit committee and the Board02020Textual Information(5)
6Thyrocare Technologies LimitedAABCT2577PPulse Hitech Health Services (Ghatkopar) LLPABCFP3978RSubsidiaryInvestment2.55Approved by the Audit committee and the Board02.362.36Textual Information(6)
7Thyrocare Technologies LimitedAABCT2577PPulse Hitech Health Services (Ghatkopar) LLPABCFP3978RSubsidiaryAny other transactionReimbursement of expenses received50As approved by the audit committee0.1100.11Textual Information(7)
8Thyrocare Technologies LimitedAABCT2577PThink Health Diagnostics Private LimitedAAJCT4450BWholly Owned SubsidiaryInvestmentApproved by the Audit committee and the Board3.50.323.82Textual Information(8)
9Thyrocare Technologies LimitedAABCT2577PThink Health Diagnostics Private LimitedAAJCT4450BWholly Owned SubsidiaryAny other transactionReimbursement of expenses received50As approved by the audit committee0.0300.04Textual Information(9)
10Thyrocare Technologies LimitedAABCT2577PThink Health Diagnostics Private LimitedAAJCT4450BWholly Owned SubsidiaryAny other transactionSecurity deposit10As approved by the audit committee1.250.752Textual Information(10)
11Thyrocare Technologies LimitedAABCT2577PThink Health Diagnostics Private LimitedAAJCT4450BWholly Owned SubsidiarySale of goods or services10As approved by the audit committee0.080.030.07Textual Information(11)
12Thyrocare Technologies LimitedAABCT2577PThink Health Diagnostics Private LimitedAAJCT4450BWholly Owned SubsidiarySale of goods or services10As approved by the audit committee0.280.440.18Textual Information(12)
13Thyrocare Technologies LimitedAABCT2577PThyrocare Laboratories (Tanzania) LimitedZZZZZ9999ZAssociate CompanyInvestment10As approved by the audit committee03.133.13Textual Information(13)
14Thyrocare Technologies LimitedAABCT2577PKasthipharm LimitedZZZZZ9999ZJoint Venture PartnerSale of goods or services10As approved by the audit committee0.060.090.15Textual Information(14)
15Thyrocare Technologies LimitedAABCT2577PKasthipharm LimitedZZZZZ9999ZJoint Venture PartnerSale of fixed assets10As approved by the audit committee00.210.21Textual Information(15)
16Thyrocare Technologies LimitedAABCT2577PKasthipharm LimitedZZZZZ9999ZJoint Venture PartnerSale of goods or services10As approved by the audit committee0.010.010.03Textual Information(16)
17Thyrocare Technologies LimitedAABCT2577PKasthipharm LimitedZZZZZ9999ZJoint Venture PartnerAny other transactionReimbursement of expenses received50As approved by the audit committee0.120.020.14Textual Information(17)
18Thyrocare Technologies LimitedAABCT2577PNueclear Healthcare LimitedAADCN5392GWholly Owned SubsidiaryInvestmentApproved by the Audit committee and the Board0150.34150.34Textual Information(18)
19Thyrocare Technologies LimitedAABCT2577PNueclear Healthcare LimitedAADCN5392GWholly Owned SubsidiaryAny other transactionReimbursement of expenses received50As approved by the audit committee0.3500Textual Information(19)
20Thyrocare Technologies LimitedAABCT2577PNueclear Healthcare LimitedAADCN5392GWholly Owned SubsidiaryAny other transactionSecurity deposit given10As approved by the audit committee00.170.17Textual Information(20)
21Thyrocare Technologies LimitedAABCT2577PNueclear Healthcare LimitedAADCN5392GWholly Owned SubsidiaryAny other transactionSecurity deposit taken10As approved by the audit committee055Textual Information(21)
22Thyrocare Technologies LimitedAABCT2577PNueclear Healthcare LimitedAADCN5392GWholly Owned SubsidiaryAny other transactionRent given10As approved by the audit committee0.500Textual Information(22)
23Thyrocare Technologies LimitedAABCT2577PNueclear Healthcare LimitedAADCN5392GWholly Owned SubsidiaryAny other transactionRent received10As approved by the audit committee0.2800Textual Information(23)
24Thyrocare Technologies LimitedAABCT2577PNueclear Healthcare LimitedAADCN5392GWholly Owned SubsidiaryAny other transactionReimbursement of expenses paid50As approved by the audit committee0.100Textual Information(24)
25Thyrocare Technologies LimitedAABCT2577PAlok Kumar JagnaniAESPJ4812MKMPRemunerationAs approved by Nomination and Remuneration committee and Board0.610.150.48Textual Information(25)
26Thyrocare Technologies LimitedAABCT2577PRahul GuhaAEOPG8099MKMPRemunerationAs approved by Nomination and Remuneration committee and Board2.0902.09Textual Information(26)
27Thyrocare Technologies LimitedAABCT2577PRamjee Dorai ADDPR1630DKMPRemunerationAs approved by Nomination and Remuneration committee and Board0.210.050.16Textual Information(27)
28Thyrocare Technologies LimitedAABCT2577PGopalkrishna Shivaram HegdeAABPH1095BIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0200Textual Information(28)
29Thyrocare Technologies LimitedAABCT2577P Neetin DesaiAIEPD2899NIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0200Textual Information(29)
30Thyrocare Technologies LimitedAABCT2577PIndumati GopinathanAFNPG2066EIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0300Textual Information(30)
31Thyrocare Technologies LimitedAABCT2577P Prapti Ishwar GiladaANGPG8714NIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0400Textual Information(31)
32Thyrocare Technologies LimitedAABCT2577PHarshil Jiten VoraAENPV4216JIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0100Textual Information(32)
33Thyrocare Technologies LimitedAABCT2577PAnandh SundarBUUPS7480PIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0100Textual Information(33)
34Thyrocare Technologies LimitedAABCT2577PNishant ShahALIPS8723KIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0100Textual Information(34)
35Nueclear Healthcare LimitedAADCN5392GAPI HOLDINGS LIMITEDAASCA1201EUltimate Holding CompanyAny other transactionRent received10As approved by the audit committee00.020Textual Information(35)
36Nueclear Healthcare LimitedAADCN5392GPulse Hitech Health Services (Ghatkopar) LLPABCFP3978RSubsidiary of Thyrocare Technologies LimitedLoan6As approved by the audit committee0.286.977.25Inter-corporate deposit0.0960 monthsUnsecured Purchase of equipmentTextual Information(36)
37Nueclear Healthcare LimitedAADCN5392GPulse Hitech Health Services (Ghatkopar) LLPABCFP3978RSubsidiary of Thyrocare Technologies LimitedInterest receivedAs approved by Audit Commitee at the rate of 9% p.a..0.050.450Textual Information(37)
38Thyrocare Technologies LimitedAABCT2577PAPI HOLDINGS LIMITEDAASCA1201EUltimate Holding CompanySale of goods or services10As approved by the audit committee0.0100Textual Information(38)
39Thyrocare Technologies LimitedAABCT2577PDocon Technologies Private LimitedAAFCD7637LHolding CompanyAny other transactionReimbursement of expenses received50As approved by the audit committee3.500Textual Information(39)
40Thyrocare Technologies LimitedAABCT2577PDocon Technologies Private LimitedAAFCD7637LHolding CompanyPurchase of goods or services10As approved by the audit committee1.6200Textual Information(40)
41Thyrocare Technologies LimitedAABCT2577PThrepsi Solutions Private LimitedAAHCT1527FFellow subsidiarySale of goods or services10As approved by the audit committee0-0.04-0.03Textual Information(41)
42Thyrocare Technologies LimitedAABCT2577PAscent Wellness & Pharma Solutions P LtdAASCA3306L Fellow subsidiaryPurchase of goods or services10As approved by the audit committee0.0100Textual Information(42)
43Thyrocare Technologies LimitedAABCT2577PAvighna Medicare Private LimitedAASCA3306LFellow subsidiarySale of goods or services10As approved by the audit committee0.5400.17Textual Information(43)
44Thyrocare Technologies LimitedAABCT2577PAvighna Medicare Private LimitedAARCA5145JFellow subsidiaryAny other transactionReimbursement of expenses received50As approved by the audit committee0.0400Textual Information(44)
45Thyrocare Technologies LimitedAABCT2577PAYRO RETAIL SOLUTIONS PRIVATE LIMITEDAAGCC8460R Fellow subsidiaryAny other transactionReimbursement of expenses received50As approved by the audit committee000Textual Information(45)
Total value of transaction during the reporting period46.94